Maan Singh

Employment

• IQVIA (India) Patent Analyst
  2020 - 2022
• IIT BHU PhD Scholar

Education

• Babasaheb Bhimrao Ambedkar University Master of Pharmacy
  2018 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Sonocrystallization approach in crystal habit modification for improving the pharmaceutical properties of Rivaroxaban
  Ultrasonics Sonochemistry 2026 DOI: 10.1016/j.ultsonch.2026.107921
  +Save
• Engineering Hydrophobic and Hydrophilic Carbon Quantum Dots from Curcumin for Spatially Controlled Liposome Integration
  Langmuir 2026 DOI: 10.1021/acs.langmuir.6c01054
  +Save
• Microneedling-assisted transdermal delivery of istradefylline nanocrystals loaded hydrogel
  Journal of Drug Delivery Science and Technology 2026 DOI: 10.1016/j.jddst.2026.108156
  +Save
• Process optimization of novel quasi-emulsion solvent diffusion technique for spherical crystallization of ethambutol hydrochloride
  Powder Technology 2026 DOI: 10.1016/j.powtec.2025.121954
  +Save
• Cocrystal Engineering-Based Strategies for Enhancing the Permeability of Poorly Permeable APIs
  Crystal Growth & Design 2025 DOI: 10.1021/acs.cgd.5c00755
  +Save
• Advancements in Computational Screening Methods for Pharmaceutical Cocrystals
  Cocrystals in Pharmaceutical Sciences: Design to Applications 2025
  +Save
• Development of novel coprocessing technique for ethambutol hydrochloride to improve its processability
  Powder Technology 2025 DOI: 10.1016/j.powtec.2025.120885
  +Save
• The impact of crystal habit on the pharmaceutical properties of active pharmaceutical ingredients
  CrystEngComm 2025 DOI: 10.1039/D4CE01170H
  +Save
• The potential of sonocrystallization in crystal habit modification for improving micromeritic and physicochemical properties of Dapagliflozin
  Chemical Engineering Research and Design 2024 DOI: 10.1016/j.cherd.2024.05.034
  +Save
• Development and comparison of machine learning models for in-vitro drug permeation prediction from microneedle patch
  European Journal of Pharmaceutics and Biopharmaceutics 2024 DOI: 10.1016/j.ejpb.2024.114311
  +Save